Lineage Cell Therapeutics Inc (LCTX)

[tjcunn]

Adi -- Your DD and willingness to share it is much appreciated. I recently acquired a modest position and hope to add as funds permit. Your thoughts on one aspect of Renevia use in the broader cosmetic market would be welcome.
It would seem that current clinicians are profiting nicely as the business is chronic and recurring with effect lasting only 6 to 8 months. It's probable that Renevia treatment will last longer, perhaps much longer. If so, might this fact dissuade some practioners from switching from the BOTOX gravy train to a new treatment that should be longer lasting thus affecting their return business? I suppose they could charge more, to mitigate loss business, and still find plenty of customers willing to pay for the newest, and better, treatment. And then with age ever new wrinkles and occasions of fat loss would keep the return business healthy to some extent. Over time, as knowledge of a superior treatment spread, more and more of the reluctant practioners would be forced to switch.
The 7B dollar market is so big that even capturing a fraction would be significantly monetarily to the company.
Do you see the reluctance by an unknown percentage of the providers as a barrier to near/mid-term acceptance of Renevia?